1. (a) In general The Secretary shall make grants for providing services for the prevention and treatment of diabetes in accordance with subsection (b).

2. (b) Services through Indian health facilities For purposes of subsection (a), services under such subsection are provided in accordance with this subsection if the services are provided through any of the following entities:

   1. (1) The Indian Health Service.
   2. (2) An Indian health program operated by an Indian tribe or tribal organization pursuant to a contract, grant, cooperative agreement, or compact with the Indian Health Service pursuant to the Indian Self-Determination Act [25 U.S.C. 5321 et seq.].
   3. (3) An urban Indian health program operated by an urban Indian organization pursuant to a grant or contract with the Indian Health Service pursuant to title V of the Indian Health Care Improvement Act [25 U.S.C. 1651 et seq.].

3. (c) Funding

   1. (1) Transferred funds Notwithstanding section 1397dd(a) of this title, from the amounts appropriated in such section for each of fiscal years 1998 through 2002, $30,000,000, to remain available until expended, is hereby transferred and made available in such fiscal year for grants under this section.

   2. (2) Appropriations For the purpose of making grants under this section, there is appropriated, out of any money in the Treasury not otherwise appropriated—

      1. (A) $70,000,000 for each of fiscal years 2001 and 2002 (which shall be combined with amounts transferred under paragraph (1) for each such fiscal years);
      2. (B) $100,000,000 for fiscal year 2003;
      3. (C) $150,000,000 for each of fiscal years 2004 through 2017;
      4. (D) $150,000,000 for each of fiscal years 2018 through 2023, to remain available until expended;
      5. (E) $155,619,196 for fiscal year 2024, to remain available until expended;
      6. (F) $159,228,188 for fiscal year 2025, to remain available until expended;
      7. (G) $200,000,000 for fiscal year 2026, to remain available until expended; and
      8. (H) $50,410,959 for the period beginning on October 1, 2026, and ending on December 31, 2026, to remain available until expended.

(July 1, 1944, ch. 373, title III, § 330C, as added Pub. L. 105–33, title IV, § 4922, Aug. 5, 1997, 111 Stat. 574; amended Pub. L. 105–174, title III, § 3001, May 1, 1998, 112 Stat. 82; Pub. L. 106–554, § 1(a)(6) [title IX, § 931(b)], Dec. 21, 2000, 114 Stat. 2763, 2763A–585; Pub. L. 107–360, § 1(b), Dec. 17, 2002, 116 Stat. 3019; Pub. L. 110–173, title III, § 302(b), Dec. 29, 2007, 121 Stat. 2515; Pub. L. 110–275, title III, § 303(b), July 15, 2008, 122 Stat. 2594; Pub. L. 111–309, title I, § 112(2), Dec. 15, 2010, 124 Stat. 3289; Pub. L. 112–240, title VI, § 625(b), Jan. 2, 2013, 126 Stat. 2353; Pub. L. 113–93, title II, § 204(b), Apr. 1, 2014, 128 Stat. 1046; Pub. L. 114–10, title II, § 213(b), Apr. 16, 2015, 129 Stat. 152; Pub. L. 115–63, title III, § 301(b), Sept. 29, 2017, 131 Stat. 1172; Pub. L. 115–96, div. C, title I, § 3102(b), Dec. 22, 2017, 131 Stat. 2049; Pub. L. 115–123, div. E, title IX, § 50902(b), Feb. 9, 2018, 132 Stat. 289; Pub. L. 116–59, div. B, title I, § 1102(b), Sept. 27, 2019, 133 Stat. 1103; Pub. L. 116–69, div. B, title I, § 1102(b), Nov. 21, 2019, 133 Stat. 1136; Pub. L. 116–94, div. N, title I, § 402(b), Dec. 20, 2019, 133 Stat. 3114; Pub. L. 116–136, div. A, title III, § 3832(b), Mar. 27, 2020, 134 Stat. 434; Pub. L. 116–159, div. C, title I, § 2102(b), Oct. 1, 2020, 134 Stat. 729; Pub. L. 116–215, div. B, title II, § 1202(b), Dec. 11, 2020, 134 Stat. 1045; Pub. L. 116–260, div. BB, title III, § 302(b), Dec. 27, 2020, 134 Stat. 2923; Pub. L. 118–15, div. B, title III, § 2322(b), Sept. 30, 2023, 137 Stat. 95; Pub. L. 118–22, div. B, title II, § 202(b), Nov. 17, 2023, 137 Stat. 120; Pub. L. 118–35, div. B, title I, § 102(b), Jan. 19, 2024, 138 Stat. 5; Pub. L. 118–42, div. G, title I, § 102(b), Mar. 9, 2024, 138 Stat. 398; Pub. L. 118–158, div. C, title I, § 3102(b), Dec. 21, 2024, 138 Stat. 1763; Pub. L. 119–4, div. B, title I, § 2102(b), Mar. 15, 2025, 139 Stat. 41; Pub. L. 119–37, div. F, title I, § 6102(b), Nov. 12, 2025, 139 Stat. 630; Pub. L. 119–75, div. J, title IV, § 6402(b), Feb. 3, 2026, 140 Stat. 687.)

Editorial Notes

References in Text

The Indian Self-Determination Act, referred to in subsec. (b)(2), is title I of Pub. L. 93–638, Jan. 4, 1975, 88 Stat. 2206, which is classified principally to subchapter I (§ 5321 et seq.) of chapter 46 of Title 25, Indians. For complete classification of this Act to the Code, see Short Title note set out under section 5301 of Title 25 and Tables.

The Indian Health Care Improvement Act, referred to in subsec. (b)(3), is Pub. L. 94–437, Sept. 30, 1976, 90 Stat. 1400. Title V of the Act is classified generally to subchapter IV (§ 1651 et seq.) of chapter 18 of Title 25, Indians. For complete classification of this Act to the Code, see Short Title note set out under section 1601 of Title 25 and Tables.

Amendments

2026—Subsec. (c)(2)(E) to (H). Pub. L. 119–75 added subpars. (E) to (H) and struck out former subpars. (E) to (H) which read as follows:

“(E) $19,726,027 for the period beginning on October 1, 2023, and ending on November 17, 2023, $25,890,411 for the period beginning on November 18, 2023, and ending on January 19, 2024, $20,136,986 for the period beginning on January 20, 2024, and ending on March 8, 2024, and $130,000,000 for the period beginning on March 9, 2024, and ending on December 31, 2024, to remain available until expended;

“(F) $39,261,745 for the period beginning on January 1, 2025, and ending on March 31, 2025, to remain available until expended;

“(G) $79,832,215 for the period beginning on April 1, 2025, and ending on September 30, 2025, to remain available until expended; and

“(H) $53,145,205 for the period beginning on October 1, 2025, and ending on January 30, 2026, to remain available until expended.”

2025—Subsec. (c)(2)(G). Pub. L. 119–4 added subpar. (G).

Subsec. (c)(2)(H). Pub. L. 119–37 added subpar. (H).

2024—Subsec. (c)(2)(E). Pub. L. 118–42 substituted “$20,136,986 for the period beginning on January 20, 2024, and ending on March 8, 2024, and $130,000,000 for the period beginning on March 9, 2024, and ending on December 31, 2024” for “and $20,136,986 for the period beginning on January 20, 2024, and ending on March 8, 2024”.

Pub. L. 118–35 substituted “$25,890,411 for the period beginning on November 18, 2023, and ending on January 19, 2024, and $20,136,986 for the period beginning on January 20, 2024, and ending on March 8, 2024” for “and $25,890,411 for the period beginning on November 18, 2023, and ending on January 19, 2024”.

Subsec. (c)(2)(F). Pub. L. 118–158 added subpar. (F).

2023—Subsec. (c)(2)(E). Pub. L. 118–22 substituted “$19,726,027 for the period beginning on October 1, 2023, and ending on November 17, 2023, and $25,890,411 for the period beginning on November 18, 2023, and ending on January 19, 2024” for “$19,726,027 for the period beginning on October 1, 2023, and ending on November 17, 2023”.

Pub. L. 118–15 added subpar. (E).

2020—Subsec. (c)(2)(D). Pub. L. 116–260 substituted “2023” for “2020, and $32,465,753 for the period beginning on October 1, 2020, and ending on December 18, 2020”.

Pub. L. 116–215 substituted “$32,465,753” for “$29,589,042” and “December 18, 2020” for “December 11, 2020”.

Pub. L. 116–159 substituted “$29,589,042” for “$25,068,493” and “December 11, 2020” for “November 30, 2020”.

Pub. L. 116–136 substituted “through 2020, and $25,068,493 for the period beginning on October 1, 2020, and ending on November 30, 2020” for “and 2019, and $96,575,342 for the period beginning on October 1, 2019, and ending on May 22, 2020”.

2019—Subsec. (c)(2)(D). Pub. L. 116–94 substituted “$96,575,342” for “$33,287,671” and “May 22, 2020” for “December 20, 2019”.

Pub. L. 116–69 substituted “$33,287,671” for “$21,369,863” and “December 20, 2019” for “November 21, 2019”.

Pub. L. 116–59 inserted “and $21,369,863 for the period beginning on October 1, 2019, and ending on November 21, 2019,” before “to remain available”.

2018—Subsec. (c)(2)(D). Pub. L. 115–123 amended subpar. (D) generally. Prior to amendment, subpar. (D) read as follows: “$37,500,000 for the first quarter of fiscal year 2018 and $37,500,000 for the second quarter of fiscal year 2018.”

2017—Subsec. (c)(2)(D). Pub. L. 115–96 inserted “and $37,500,000 for the second quarter of fiscal year 2018” before period at end.

Pub. L. 115–63 added subpar. (D).

2015—Subsec. (c)(2)(C). Pub. L. 114–10 substituted “2017” for “2015”.

2014—Subsec. (c)(2)(C). Pub. L. 113–93 substituted “2015” for “2014”.

2013—Subsec. (c)(2)(C). Pub. L. 112–240 substituted “2014” for “2013”.

2010—Subsec. (c)(2)(C). Pub. L. 111–309 substituted “2013” for “2011”.

2008—Subsec. (c)(2)(C). Pub. L. 110–275 substituted “2011” for “2009”.

2007—Subsec. (c)(2)(C). Pub. L. 110–173 substituted “2009” for “2008”.

2002—Subsec. (c)(2)(C). Pub. L. 107–360 added subpar. (C).

2000—Subsec. (c). Pub. L. 106–554 designated existing provisions as par. (1), inserted par. heading, and added par. (2).

1998—Subsec. (c). Pub. L. 105–174 inserted “, to remain available until expended,” after “fiscal years 1998 through 2002, $30,000,000”.

Statutory Notes and Related Subsidiaries

Funds Available Until Expended

Pub. L. 108–7, div. F, title II, Feb. 20, 2003, 117 Stat. 261, provided in part “That funds appropriated under the Special Diabetes Program for Indians (42 U.S.C. 254c–3(c)) for fiscal year 2003 and thereafter for the purpose of making grants shall remain available until expended”.